Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of NBQ72S in breast cancer leptomeningeal metastases
CTR20251118Phase 2Active
- Sponsor
- Nantong Bencao Bada Pharmaceutical Technology
- Start
- Mar 2025
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QBS10072S in breast cancer, sponsored by Nantong Bencao Bada Pharmaceutical Technology. Started Mar 2025; status: active.
02
Drugs
QBS10072S
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20251118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251118.